01-01-1970 12:00 AM | Source: Accord Fintech
Shilpa Medicare gets GMP certificate from MOH-Russia for API facility in Karnataka
Shilpa Medicare has received GMP certificate from MOH-Russia for its API facility (unit-1) located at Raichur, Karnataka. The facility was audited by the agency on February 17, 2022, February 18, 2022 and February 21, 2022. The facility involves in manufacturing, testing, packing, storage of chemically synthesized nonsterile drug substances for human use.
Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
Latest News
Evening Roundup : A Daily Report on Bullion Energy &...
Sensex jumps 253 points after robust Q4 earnings
ABANS Holdings Limited declares its financial result...
Daily Market Analysis : The market edged higher, con...
Samco MF introduces Special Opportunities Fund
Economic priorities will have to align with our stra...
Paytm travel carnival offers deals on domestic fligh...
India`s SAIL keenly watching Chinese steel imports p...
India`s Mahindra & Mahindra jumps most in over three...
Space data fuels India`s farming innovation drive